Click for more information

laboratory
services

Key Subsectors

Diagnostic Testing

Regulatory Testing

Manufacturing Support

Current Investments

Bako

GENEWIZ

Prior Investments

Accuratus Lab Services

Signature Genomic Laboratories

Viracor-IBT Laboratories

Ampersand Case Study: Viracor-IBT Laboratories

Close
laboratory
products

Key Subsectors

Scientific Products

Diagnostic Products

Specialty Distribution

Current Investments

Dynex Technologies

Gyros Protein Technologies

Prior Investments

Aclara Biosciences

Assay Designs

Magellan Diagnostics

TriPath Imaging (Nasdaq: TPTH)

Close
contract
manufacturing

Key Subsectors

Medical Devices and Components

Nutritionals and Ingredients

Current Investments

Confluent Medical Technologies

Corpus Medical

Elite One Source Nutrisciences

Innovative Food Processors

Prior Investments

MedVenture Technology

Ortho Organizers

Close
pharma
services

Key Subsectors

Pre Clinical Services

Clinical Trial Support

Outsourced Production

Current Investments

Avista Pharma Solutions

Brammer Bio

LakePharma

Prior Investments

Agilux Laboratories

BioClinica

ChanTest

CoreLab Partners

CRI Lifetree

Close
specialty
pharma

Key Subsectors

Complex Manufacturing

Specialty Distribution

Current Investments

Bioventus

CutisPharma

Roadrunner Pharmacy

Prior Investments

Talecris Biotherapeutics (Grifols, SA)

Victory Pharma

Close

Target Healthcare Sectors

Ampersand has over two decades of experience in helping build middle market healthcare companies into market leaders.  We focus on EBITDA-positive companies that provide products or services within several key healthcare sectors, including laboratory testing services, laboratory products, contract manufacturing, pharma services and specialty pharma.  Ampersand brings significant prior experience to each of these sectors, allowing us to partner with entrepreneurs in taking their companies to the next level.

Investment Criteria

Company Size

Typically $10 to $100 million of revenue

Investment Size

$10 to $30 million of equity
Use of leverage when appropriate

Ownership

Either majority or minority positions

Role

First institutional investor

Use of Capital

Business expansion / growth equity
Recapitalizations / shareholder equity
Management buyouts
Corporate divestitures

Geography

North America

Target Healthcare Sectors

Laboratory Services
Laboratory Products
Contract Manufacturing
Pharma Services
Specialty Pharma